Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Next-Generation ...

The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue ...

Routine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the ...